9 chapters across the catalog
John Dvorak provides a health update, mentioning his use of a telemetry monitor and his interactions with a new dietitian who uses modern research rather than the "1950s pyramid." He discusses the challenges of recovering from his recent operation, including issues with "dry mouth" and monitoring his phosphorus levels. Dvorak also mentions walking around his neighborhood and visiting a Mexican market as part of his recovery.
Frontier AI Models, $100 Billion Entry Price, Cancer Detection Claims
Larry Ellison stated that the entry price for a "frontier" AI model will soon reach $100 billion over the next four to five years. He claimed that specialized AI models will revolutionize healthcare by detecting cancer through blood tests and CAT scans. These assertions are compared to the failed promises of Theranos, questioning the actual utility of AI in medical diagnostics.
French Company Alstiag Develops Bipolar Disorder Blood Test
French company Alstiag has launched a blood test that uses AI to differentiate between depression and bipolar disorder by analyzing RNA sequences. The test aims to reduce misdiagnosis rates, which currently take six to eight years on average in France. While the company claims an 80% accuracy rate, skeptics question the validity of using a month-long blood analysis to diagnose complex mental health conditions.
Depression Blood Tests, Stress Immunity, Mount Sinai Research
Researchers at Johns Hopkins and Mount Sinai are developing blood tests to diagnose depression and measure stress-related immune function. The studies suggest that stress increases an enzyme in the blood that alters brain function and reduces the body's ability to fight disease. Critics argue this "brain chemistry" narrative is designed to promote expensive testing and pharmaceutical interventions rather than addressing environmental or psychological causes.
Immunity and Reinfection, Antibody Testing in China
Dr. Anthony Fauci expressed confidence that individuals who recover from COVID-19 would develop immunity against reinfection, though he noted a lack of formal studies. Reports from China indicated that many people developed antibodies despite showing no symptoms. Researchers suggested that even if reinfection occurred, the subsequent disease would likely be much less severe.
Mark Shields, Blood Money and Special Privilege
Political analyst Mark Shields criticized the "special privilege" shown to the Utah Jazz basketball team, who received immediate testing while frontline healthcare workers were denied. He characterized the profits made by senators from timely stock sales as "blood money" that must be prosecuted.
United Biomedical Countywide Blood Testing in Colorado
San Miguel County, Colorado, is implementing a first-in-the-nation countywide blood test for coronavirus in partnership with United Biomedical. The hosts express suspicion toward the company, noting its affiliations with Chinese biomedical firms and Mandarin text on its website. President Trump also announced efforts to develop "self-swab" tests to replace the invasive nasal swabs currently in use.
The role of the Theranos board, which included figures like Henry Kissinger and George Shultz, is examined alongside the culpability of venture capital firms. The hosts suggest that experienced investors should have recognized the technical impossibilities of the Edison machine. They contrast the Theranos scandal with the established blood-testing industry giants like LabCorp.
World Anti-Doping Agency, Lance Armstrong Vendetta
The World Anti-Doping Agency (WADA) is investigating allegations of widespread doping in international athletics following a data leak. The conversation references the downfall of Lance Armstrong, suggesting his case was driven by a personal vendetta.
